Universal Health (UHT) Fundamental Analysis: Revenue, Earnings & Valuation

2.86 / 10

Underperform

Fundamental analysis rates UHT as Underperform with a 2.9/10 quality score. Positive drivers include Asset‑MV and PB‑ROE, but cash growth and net‑asset‑per‑share growth are negative, dragging overall fundamentals down. Investors should view the balance sheet and earnings trends with caution.

Analysis Checks(3/10)

Revenue-MV

Value-1.25

Score1/3

Weight22.19%

1M Return3.18%

Net assets per share (growth rate compared to beginning of year %)

Value-15.27

Score0/3

Weight-4.69%

1M Return-1.04%

Total operating revenue (YoY growth rate %)

Value0.18

Score0/3

Weight-9.11%

1M Return-1.96%

Profit-MV

Value0.22

Score1/3

Weight20.13%

1M Return3.42%

Net income-Revenue

Value-0.04

Score2/3

Weight37.20%

1M Return4.88%

PB-ROE

Value-0.10

Score2/3

Weight19.36%

1M Return3.27%

Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)

Value-15.13

Score1/3

Weight-3.04%

1M Return-0.70%

Income tax / Total profit (%)

Value21.05

Score0/3

Weight-4.58%

1M Return-0.94%

Cash-UP

Value-0.10

Score1/3

Weight15.52%

1M Return2.62%

Asset-MV

Value0.04

Score2/3

Weight7.02%

1M Return1.04%

Is UHT undervalued or overvalued?

UHT scores 2.86/10 on fundamentals and holds a Premium valuation at present. Backed by its 10.61% ROE, 17.75% net margin, 31.36 P/E ratio, 3.62 P/B ratio, and -8.63% earnings growth, these metrics solidify its Underperform investment rating.